826 related articles for article (PubMed ID: 17398022)
1. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
[TBL] [Abstract][Full Text] [Related]
3. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma.
Vera-Llonch M; Oster G; Hagiwara M; Sonis S
Cancer; 2006 Jan; 106(2):329-36. PubMed ID: 16342066
[TBL] [Abstract][Full Text] [Related]
4. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
5. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3).
Bjarnason GA; Mackenzie RG; Nabid A; Hodson ID; El-Sayed S; Grimard L; Brundage M; Wright J; Hay J; Ganguly P; Leong C; Wilson J; Jordan RC; Walker M; Tu D; Parulekar W;
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):166-72. PubMed ID: 18805649
[TBL] [Abstract][Full Text] [Related]
6. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life.
Elting LS; Keefe DM; Sonis ST; Garden AS; Spijkervet FK; Barasch A; Tishler RB; Canty TP; Kudrimoti MK; Vera-Llonch M;
Cancer; 2008 Nov; 113(10):2704-13. PubMed ID: 18973181
[TBL] [Abstract][Full Text] [Related]
8. Oral mucositis.
Sonis ST
Anticancer Drugs; 2011 Aug; 22(7):607-12. PubMed ID: 21709615
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
[TBL] [Abstract][Full Text] [Related]
10. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.
Elting LS; Cooksley C; Chambers M; Cantor SB; Manzullo E; Rubenstein EB
Cancer; 2003 Oct; 98(7):1531-9. PubMed ID: 14508842
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy.
Murphy BA
J Support Oncol; 2007 Oct; 5(9 Suppl 4):13-21. PubMed ID: 18046994
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
Epstein JB; Beaumont JL; Gwede CK; Murphy B; Garden AS; Meredith R; Le QT; Brizel D; Isitt J; Cella D
Cancer; 2007 May; 109(9):1914-22. PubMed ID: 17377917
[TBL] [Abstract][Full Text] [Related]
13. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
14. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
[TBL] [Abstract][Full Text] [Related]
15. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
16. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial.
Kazemian A; Kamian S; Aghili M; Hashemi FA; Haddad P
Eur J Cancer Care (Engl); 2009 Mar; 18(2):174-8. PubMed ID: 19267733
[TBL] [Abstract][Full Text] [Related]
17. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
Murphy BA; Beaumont JL; Isitt J; Garden AS; Gwede CK; Trotti AM; Meredith RF; Epstein JB; Le QT; Brizel DM; Bellm LA; Wells N; Cella D
J Pain Symptom Manage; 2009 Oct; 38(4):522-32. PubMed ID: 19608377
[TBL] [Abstract][Full Text] [Related]
18. [Radiation-induced mucositis and neutrophil granulocytes in oral mucosa].
Schmidberger H; Rave-Fränk M; Kim S; Hille A; Pradier O; Hess CF
Strahlenther Onkol; 2003 Oct; 179(10):667-72. PubMed ID: 14566474
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
20. Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy-induced oral mucositis: comparison between low and high/low power lasers.
Simões A; Eduardo FP; Luiz AC; Campos L; Sá PH; Cristófaro M; Marques MM; Eduardo CP
Lasers Surg Med; 2009 Apr; 41(4):264-70. PubMed ID: 19347940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
